Back to KROS

CITADEL ADVISORS LLC → KROS

CITADEL ADVISORS LLC KROS Position History

Keros Therapeutics, Inc. • Healthcare

Quarters held
11
Latest value
$1.9M
Q3 2026
Peak value
$3.1M
First seen
Q1 2026

Dollar value over time

Show data table
PeriodPosition value
Q1 2026$2.6M
Q1 2026$190K
Q1 2026$1.9M
Q1 2026$1.4M
Q2 2026$3.1M
Q2 2026$1.1M
Q2 2026$154K
Q2 2026$3.1M
Q2 2026$1.1M
Q2 2026$154K
Q3 2026$1.9M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$1.9M162.7K——
Q2 2026$154K14.4K——
Q2 2026$1.1M106.8K——
Q2 2026$3.1M289.3K——
Q2 2026$154K14.4K——
Q2 2026$1.1M106.8K——
Q2 2026$3.1M289.3K——
Q1 2026$1.4M129.9K——
Q1 2026$1.9M174.1K——
Q1 2026$190K17.2K——
Q1 2026$2.6M232.5K——

Other funds holding KROS

$288.7M
$240.4M
$182.8M
$175.4M
$171.8M
$163.6M
$161.9M
$144.3M

Other CITADEL ADVISORS LLC positions

ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$11.2B
SPY

SPDR S&P 500 ETF TR

$3B
MSFT

MICROSOFT CORP

$2.9B
ETHA

ISHARES TR

$2.7B
SPY

SPDR S&P 500 ETF TR

$2.6B
SPY

STATE STR SPDR S&P 500 ETF T

$2.4B